| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tandem Diabetes Care Inc (TNDM) has 17 insiders with recent SEC Form 4 filings, including 13 buys and 6 sells. TNDM is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| VP | 41.2K | $638.3K | - | |
| CFO | 39.4K | $610.1K | - | |
| VP | 36.0K | $556.6K | - | |
| VP | 25.9K | $401.7K | - | |
| Other | 24.5K | $378.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 18, 2023 | Allen Dick69 | Director | Buy | 10,000 | $29.47 | $294,687.00 | +453.5% | -5.9% | +59.7% | |
| May 17, 2023 | Howell Peyton R | Director | Buy | 3,000 | $30.16 | $90,492.00 | +54.1% | -5.0% | +54.3% | |
| May 12, 2023 | Vosseller Leigh74 | EVP &Chief Financial Officer | Buy | 3,015 | $32.77 | $98,805.47 | +114.0% | -11.1% | +34.6% | |
| Mar 3, 2023 | Berger David B79 | EVP &Chief Operating Officer | Sale+OE | 10,000 | $41.19 | $411,884.00 | -74.8% | -41.0% | -33.7% | |
| Dec 16, 2022 | Berger David B79 | EVP &Chief Operating Officer | Sale+OE | 25,000 | $40.29 | $1,007,300.00 | -80.5% | -0.1% | -30.9% | |
| Jun 8, 2022 | Berger David B79 | EVP &Chief Operating Officer | Sale+OE | 10,097 | $65.02 | $656,515.00 | -55.8% | -33.7% | -63.4% | |
| May 17, 2022 | Blickenstaff Kim D61 | Director | Sale+OE | 10,762 | $92.91 | $999,897.42 | -5.0% | -26.0% | -59.3% | |
| May 9, 2022 | Sheridan John F51 | President &CEO | Buy | 2,500 | $69.90 | $174,750.00 | +33.1% | -13.5% | -52.9% | |
| May 9, 2022 | Vosseller Leigh74 | EVP &Chief Financial Officer | Buy | 2,500 | $74.61 | $186,527.60 | +10.9% | -13.5% | -52.9% | |
| May 6, 2022 | Howell Peyton R | Director | Buy | 2,000 | $74.85 | $149,694.72 | +22.1% | -22.9% | -53.9% |